The generic pharmaceutical market in South Africa: At the crossroads?

Journal of Generic Medicines

Volumn 6, Issue 2, 2009, Pages 137-144

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG CONTROL; DRUG COST; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MARKETING; DRUG QUALITY; DRUG SAFETY; DRUG UTILIZATION; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATENT; PRESCRIPTION; SOUTH AFRICA;

EID: 65549083983     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2009.2     Document Type: Article

References (11)

1. IMS South Africa (2008) IMS Health (Pty) Ltd. TPM Report, June.
2. South Africa Pharmaceuticals & Healthcare Report Q3 2006 (2006) Business Monitor International, September.
3. South African National Drug Policy, http://www.doh.gov.za, accessed 20 October 2008.
4. Generics market will reach US$68 bn. Generics Bulletin, Vol.237, 30 October 2008.
5. Vision and objectives, http://www.napm.co.za, accessed 18 October 2008.
6. Mediscor Pharmaceutical Benefit Management, Medicines Review 2007.
7. Mid-year population estimates, South Africa: July 2007, Statistics South Africa, Statistical release P0302, http://www.statssa.gov.za/ publications, accessed 21 October 2008.
8. Press Release issued by the Department of Health June 2008, http://www.doh.gov.za/docs/pr/2008/pr0626.html, accessed 18 October 2008.
9. Frequently asked questions, http://www.doh.gov.za, accessed 20 October 2008.
10. Enterprise investment programme, http://www.thedti.gov.za, accessed 21 October 2008.
11. MCC Home, http://www.mccza.com, accessed 21 October 2008.